Showing results (81-90 of 282) with videos related to

Sort By:
Pageof 29
Therapeutic Advances in Hematology|April 2, 2014
Outcomes of patients with myelodysplatic syndrome and chronic myelomonocytic leukemia post clofarabine failureHady Ghanem, Guillermo Garcia-Manero, Stefan Faderl, et al.
Leukemia Research|July 6, 2004
Extramedullary relapse in a patient with acute promyelocytic leukemia: successful treatment with arsenic trioxide, all-trans retinoic acid and gemtuzumab ozogamicin therapiesApostolia-Maria Tsimberidou, Elihu Estey, Gary J Whitman, et al.
Blood|July 31, 2013
Clinical characteristics and outcomes of therapy-related chronic myelomonocytic leukemiaKoichi Takahashi, Naveen Pemmaraju, Paolo Strati, et al.
Clinical Lymphoma, Myeloma & Leukemia|December 3, 2014
A phase I/II study of the Janus kinase (JAK)1 and 2 inhibitor ruxolitinib in patients with relapsed or refractory acute myeloid leukemiaNaveen Pemmaraju, Hagop Kantarjian, Tapan Kadia, et al.
Leukemia Research|July 30, 2013
Modest activity of pomalidomide in patients with myelofibrosis and significant anemiaNaval Daver, Aditi Shastri, Tapan Kadia, et al.
American Journal of Hematology|November 20, 2014
Prognostic factors for outcome in patients with refractory and relapsed acute lymphocytic leukemia treated with inotuzumab ozogamicin, a CD22 monoclonal antibodyElias Jabbour, Susan O'Brien, Xuelin Huang, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|October 14, 2009
Quantifying the survival benefit for allogeneic hematopoietic stem cell transplantation in relapsed acute myelogenous leukemiaPaul M Armistead, Marcos de Lima, Sherry Pierce, et al.
Cancer|July 16, 2008
Myeloid sarcoma is associated with superior event-free survival and overall survival compared with acute myeloid leukemiaApostolia-Maria Tsimberidou, Hagop M Kantarjian, Sijin Wen, et al.
Cancer|August 20, 2009
The heterogeneous prognosis of patients with myelodysplastic syndrome and chromosome 5 abnormalities: how does it relate to the original lenalidomide experience in MDS?Hagop Kantarjian, Susan O'Brien, Farhad Ravandi, et al.
Clinical Lymphoma, Myeloma & Leukemia|September 25, 2013
Similar outcome of patients with chronic myeloid leukemia treated with imatinib in or out of clinical trialsMusa Yilmaz, Hagop Kantarjian, Elias Jabbour, et al.
Pageof 29